The tyrosine kinase inhibitor (TKI) market is witnessing rapid expansion as precision medicine and targeted therapies continue to transform oncology and chronic disease treatment. Tyrosine kinase inhibitors block enzymes responsible for cell signaling pathways that regulate growth and division, making them highly effective in treating cancers and certain autoimmune disorders. With rising cancer...